Mikhail Chernov

500 total citations
8 papers, 390 citations indexed

About

Mikhail Chernov is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Mikhail Chernov has authored 8 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Cell Biology. Recurrent topics in Mikhail Chernov's work include Cancer, Hypoxia, and Metabolism (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mikhail Chernov is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Ubiquitin and proteasome pathways (2 papers). Mikhail Chernov collaborates with scholars based in United States, India and Türkiye. Mikhail Chernov's co-authors include Bryan Williams, George R. Stark, Kee Chuan Goh, Hannah Nguyen, Chilakamarti V. Ramana, Nicholas Grammatikakis, Sougata Saha, Anna Kashina, Yingyu Ma and Donald L. Trump and has published in prestigious journals such as Nature Communications, The EMBO Journal and Cancer Research.

In The Last Decade

Mikhail Chernov

8 papers receiving 384 citations

Peers

Mikhail Chernov

MB

ONCOL

IMMUN

CR

PFM

Jocelyn S. Downey United Kingdom

Jun Hong United States

Daniela Kassahn Switzerland

Melissa A. Henriksen United States

Marie Thérèse Auffredou France

Jie Xiong China

Rasmus Boye Kjellerup Denmark

Pegah Johansson Sweden

Anne-Sophie Gallouët France

Eun Gene Sun South Korea

Jocelyn S. Downey United Kingdom

Mikhail Chernov

334 ×1.7

MB

141 ×0.7

ONCOL

132 ×0.9

IMMUN

109 ×1.6

CR

35 ×0.7

PFM

Citations per year, relative to Mikhail Chernov Mikhail Chernov (= 1×) peers Jocelyn S. Downey

Countries citing papers authored by Mikhail Chernov

Since Specialization

Citations

This map shows the geographic impact of Mikhail Chernov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Chernov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Chernov more than expected).

Fields of papers citing papers by Mikhail Chernov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Chernov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Chernov. The network helps show where Mikhail Chernov may publish in the future.

Co-authorship network of co-authors of Mikhail Chernov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Chernov. A scholar is included among the top collaborators of Mikhail Chernov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Chernov. Mikhail Chernov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Shen, He, Yanmin Chen, Tao Liu, et al.. (2021). Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach. Frontiers in Cell and Developmental Biology. 9. 673374–673374. 7 indexed citations

2.

Saatci, Özge, Özge Akbulut, Carolyn E. Banister, et al.. (2021). Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer via targeting lysyl oxidase (LOX). Cancer Research. 81(5_Supplement). LT015–LT015. 1 indexed citations

3.

Yang, Xinyuan, He Shen, Yanmin Chen, et al.. (2018). NTRK1 is a positive regulator of YAP oncogenic function. Oncogene. 38(15). 2778–2787. 20 indexed citations

4.

Zhang, Fangliang, Devang M. Patel, Irina A. Rodionova, et al.. (2015). Arginylation regulates purine nucleotide biosynthesis by enhancing the activity of phosphoribosyl pyrophosphate synthase. Nature Communications. 6(1). 7517–7517. 33 indexed citations

5.

Luo, Wei, Weidong Yu, Yingyu Ma, et al.. (2013). Inhibition of Protein Kinase CK2 Reduces Cyp24a1 Expression and Enhances 1,25-Dihydroxyvitamin D3 Antitumor Activity in Human Prostate Cancer Cells. Cancer Research. 73(7). 2289–2297. 33 indexed citations

6.

Saha, Sougata, Junling Wang, Qingqing Wang, et al.. (2012). Small molecule inhibitors of arginyltransferase regulate arginylation-dependent protein degradation, cell motility, and angiogenesis. Biochemical Pharmacology. 83(7). 866–873. 27 indexed citations

7.

Chernov, Mikhail, et al.. (2011). Identification of low-molecular weight inhibitors of HIV-1 reverse transcriptase using a cell-based high-throughput screening system. Antiviral Research. 91(2). 94–98. 9 indexed citations

8.

Ramana, Chilakamarti V., Nicholas Grammatikakis, Mikhail Chernov, et al.. (2000). Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways. The EMBO Journal. 19(2). 263–272. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact